Alembic Pharmaceuticals Limited — Board Meeting, 15-05-2026: Outcome of Board Meeting

Alembic Pharmaceuticals' board approved consolidated financial results for FY26. Revenue hit ₹7,344.90 Cr, with profit at ₹674.77 Cr. The board also proposed a dividend of ₹12 per share (600%).